Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/26/2010US20100215729 Oligonucleotide analogues incorporating 5-aza-cytosine therein
08/26/2010US20100215728 Skincare Methods
08/26/2010US20100215727 Stabilized picoplatin dosage form
08/26/2010US20100215726 Compositions for Diminishing the Appearance of Wrinkles
08/26/2010US20100215725 Pharmaceutical composition containing idebenone for the treatment of liver disorders
08/26/2010US20100215724 Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
08/26/2010US20100215723 Wound Dressing with Antimicrobial Gauze and Bonding Agent
08/26/2010US20100215722 Tissue Regeneration II
08/26/2010US20100215721 Poultice and process for producing the poultice
08/26/2010US20100215719 Polyarylates for drug delivery and tissue engineering
08/26/2010US20100215717 Endothelial scaffolds
08/26/2010US20100215714 Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/26/2010US20100215708 Coating of devices with effector compounds
08/26/2010US20100215707 Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
08/26/2010US20100215704 Methods and products for improving wound healing
08/26/2010US20100215702 Microparticles comprising pcl and uses thereof
08/26/2010US20100215699 Lactoferrin as a radioprotective agent
08/26/2010US20100215672 Preparation process and utilization of Poncirus compositions having anti-allergic and antianaphylactic properties
08/26/2010US20100215590 Micronization Method
08/26/2010US20100215589 Carbamate Stereoisomer
08/26/2010US20100215588 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system
08/26/2010US20100215582 Liposome and method for producing liposome
08/26/2010US20100215580 Compositions and methods for enhancing transport through mucus
08/26/2010US20100213628 Methods and compositions for encapsulating active agents
08/26/2010US20100212667 Drug capsules for dry powder inhalers
08/26/2010DE102009001041A1 Notfallset zur Herstellung eines Arzneimittels zur nasalen Anwendung von Opioiden bei Atemnot Emergency kit for the preparation of a medicament for nasal administration of opioids for breathlessness
08/26/2010CA2788777A1 Policosanol nanoparticles
08/26/2010CA2759667A1 Particles comprising drospirenone encapsulated in a polymer
08/26/2010CA2753444A1 Controlled-release compositions comprising a proton pump inhibitor
08/26/2010CA2753416A1 Controlled release compositions comprising anti-cholinergic drugs
08/26/2010CA2753162A1 Amphiphilic compounds and self-assembling compositions made therefrom
08/26/2010CA2753099A1 Modifications of cupredoxin derived peptides and methods of use thereof
08/26/2010CA2753052A1 Pressure sensitive adhesive composition and pressure sensitive adhesive tape
08/26/2010CA2752902A1 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
08/26/2010CA2752805A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
08/26/2010CA2752296A1 Ph-modulated formulations for pulmonary delivery
08/26/2010CA2747395A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/25/2010EP2221064A1 Humanized antibodies that recognize beta amyloid peptide
08/25/2010EP2221058A1 Antimelancholic medicine prepared with jujube camp materials
08/25/2010EP2221050A1 Use of microparticles for vaccines and the release of biologically active molecules
08/25/2010EP2221049A2 Solid pharmaceutical composition of ded anosine
08/25/2010EP2221048A1 Pharmaceutical composition for inhalation
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2221030A1 Implantable electrode
08/25/2010EP2219775A1 Hollow multi-layered microspheres for delivery of hydrophilic active compounds
08/25/2010EP2219771A1 Process and arrangement for producing particles utilizing subcritical fluids
08/25/2010EP2219679A1 Cross-linked hydrogel containing an active substance
08/25/2010EP2219665A1 Parathyroid hormone formulations and uses thereof
08/25/2010EP2219644A2 Solid compositions
08/25/2010EP2219640A2 Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same
08/25/2010EP2219626A1 Process for manufacturing chewable dosage forms for drug delivery and products thereof
08/25/2010EP2219625A1 Drug-containing nanoparticles
08/25/2010EP2219624A2 Pharmaceutical formulations
08/25/2010EP2219623A1 Pharmaceutical dosage form comprising a liquid or flowable core composition
08/25/2010EP2219622A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
08/25/2010EP2219621A2 Tri-molecular complexes and their use in drug delivery systems
08/25/2010EP2219620A1 Viscous terpolymers as drug delivery platform
08/25/2010EP2219619A1 Disulfide chemotherapeutic agents and methods of use thereof
08/25/2010EP2219618A2 Pharmaceutical formulations for the oral administration of ppi
08/25/2010EP2219617A1 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
08/25/2010EP2219616A2 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same
08/25/2010EP2219615A2 Improved pharmaceutical dry powder compositions for inhalation
08/25/2010EP2219614A1 Pharmaceutical composition of orlistat
08/25/2010EP2219613A1 Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation
08/25/2010EP2219612A1 Misuse preventative, controlled release formulation
08/25/2010EP2219611A1 Pharmaceutical forms for the release of active compounds
08/25/2010EP2219610A2 Compositions containing capsaicinoids
08/25/2010EP2219609A2 Immuno-modulatory composition
08/25/2010EP2219608A1 Self solidifying bioerodible barrier implant
08/25/2010EP2219607A1 Lh liquid formulations
08/25/2010EP2219605A1 Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents
08/25/2010EP2219604A2 Biomaterial for the controlled delivery of ingredients
08/25/2010EP2219603A1 Transdermal delivery system
08/25/2010EP2219602A1 Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
08/25/2010EP2219601A2 Non-aqueous water-miscible materials as vehicles for drug delivery
08/25/2010EP2219600A1 Topical cosmetic skin lightening compositions and methods of use thereof
08/25/2010EP2219599A2 Clonidine formulations in a biodegradable polymer carrier
08/25/2010EP2219595A1 Polysaccharide gel formulation
08/25/2010EP2047855B1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants)
08/25/2010EP1895994B1 Multilayer drug delivery system with barrier against reservoir material flow
08/25/2010EP1755647B1 Treatment of amyotrophic lateral sclerosis
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1541161B1 Tablet composition containing chinese orthodox medicine extract and process for producing the same
08/25/2010EP1474109B1 Use of synthetic inorganic nanoparticles as carriers for ophthalmic drugs
08/25/2010EP1406593B1 Biodegradable polymer compositions, compositions and uses related thereto
08/25/2010EP1324755B1 Pharmaceutical solutions of modafinil compounds
08/25/2010EP1299494B1 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
08/25/2010EP0748228B8 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM
08/25/2010CN201558334U Fuyuekang capsule granule coated with film-coating
08/25/2010CN201558333U Anti-hyperosteogeny pill coated with film-coating
08/25/2010CN201558332U Arthritis black plaster
08/25/2010CN201558331U Cylinder-shaped easily-divided western medicine tablet
08/25/2010CN201558330U Cylinder-shaped tablet
08/25/2010CN1985902B Chinese medicine for treating chronic hepatopathy
08/25/2010CN1978448B 10-hydroxy camptothecin arginine salt, and its preparing method and use
08/25/2010CN1977972B Anti tumour drug oral colon targeting preparation and its preparing method
08/25/2010CN1969876B Lyophilized injection of lentinan and preparation process thereof
08/25/2010CN1969847B Pharmaceutical composition
08/25/2010CN1947743B Application of Xuesilian for preparing medicine for treating hypertension
1 ... 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 ... 2991